Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction

Aim. To determine the concentration of the stimulating growth factor ST2 and its relationship to the clinical course of myocardial infarction (MI) over time during hospitalization. Subjects and methods. Eighty-eight MI patients whose mean age was 59±8.36 years were examined. On days 1 and 12 of MI,...

Full description

Bibliographic Details
Main Authors: O V Gruzdeva, O E Akbasheva, E G Uchasova, Yu A Dyleva, N V Fedorova, V N Karetnikova, V V Kashtalap, O L Barbarash
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2016-04-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/31952/pdf
id doaj-16cbc017402243d885c450796f4ac385
record_format Article
spelling doaj-16cbc017402243d885c450796f4ac3852020-11-25T03:04:45Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422016-04-0188491528968Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarctionO V GruzdevaO E AkbashevaE G UchasovaYu A DylevaN V FedorovaV N KaretnikovaV V KashtalapO L BarbarashAim. To determine the concentration of the stimulating growth factor ST2 and its relationship to the clinical course of myocardial infarction (MI) over time during hospitalization. Subjects and methods. Eighty-eight MI patients whose mean age was 59±8.36 years were examined. On days 1 and 12 of MI, the serum levels of ST2 and N-terminal pro-brain natriuretic peptide (NT-proBNP) were determined by ELISA. A control group consisted of 30 people. Results. On day 1 of hospitalization for MI, the concentrations of ST2 and NT-proBNP were higher 2.4 and 4.5 times, respectively, than those in the controls; by day 12, there was a statistically significant decrease in the level of ST2 while that of NT-proBNP was unchanged. During hospitalization, the investigators recorded MI complications, according to which the patients were divided into favorable and unfavorable MI groups. On day 1 of hospitalization, the level of ST2 in the patients with unfavorable MI was twice higher than in those with favorable MI and 3.7 times higher than in the control group. On day 12, both favorable and unfavorable MI groups showed a reduction in the level of the marker. On day 1 of MI, the concentration of NT-proBNP in the patients with a poor prognosis was 6.8 times greater than in the controls and 1.8 times more than in the patients with a good prognosis. On day 12, NT-proBNP levels remained elevated in both groups. Logistic regression analysis revealed that the determination of ST2 in combination with NT-proBNP increased their diagnostic significance (odds ratio, 1.92; 95% CI, 1.7—3.2; area under characteristic curve, 0.89; p=0.004). Conclusion. The level of ST2 was a more sensitive indicator of hospitalization for MI than that of NT-proBNP. The combined use of ST2 and NT-proBNP was found to have a high diagnostic sensitivity and specificity.https://ter-arkhiv.ru/0040-3660/article/viewFile/31952/pdfmyocardial infarctionhospitalizationstimulating growth factor st2n-terminal pro-brain natriuretic peptide (nt-probnp)
collection DOAJ
language Russian
format Article
sources DOAJ
author O V Gruzdeva
O E Akbasheva
E G Uchasova
Yu A Dyleva
N V Fedorova
V N Karetnikova
V V Kashtalap
O L Barbarash
spellingShingle O V Gruzdeva
O E Akbasheva
E G Uchasova
Yu A Dyleva
N V Fedorova
V N Karetnikova
V V Kashtalap
O L Barbarash
Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction
Терапевтический архив
myocardial infarction
hospitalization
stimulating growth factor st2
n-terminal pro-brain natriuretic peptide (nt-probnp)
author_facet O V Gruzdeva
O E Akbasheva
E G Uchasova
Yu A Dyleva
N V Fedorova
V N Karetnikova
V V Kashtalap
O L Barbarash
author_sort O V Gruzdeva
title Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction
title_short Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction
title_full Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction
title_fullStr Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction
title_full_unstemmed Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction
title_sort diagnostic value of the stimulating growth factor st2 during hospitalization for myocardial infarction
publisher "Consilium Medicum" Publishing house
series Терапевтический архив
issn 0040-3660
2309-5342
publishDate 2016-04-01
description Aim. To determine the concentration of the stimulating growth factor ST2 and its relationship to the clinical course of myocardial infarction (MI) over time during hospitalization. Subjects and methods. Eighty-eight MI patients whose mean age was 59±8.36 years were examined. On days 1 and 12 of MI, the serum levels of ST2 and N-terminal pro-brain natriuretic peptide (NT-proBNP) were determined by ELISA. A control group consisted of 30 people. Results. On day 1 of hospitalization for MI, the concentrations of ST2 and NT-proBNP were higher 2.4 and 4.5 times, respectively, than those in the controls; by day 12, there was a statistically significant decrease in the level of ST2 while that of NT-proBNP was unchanged. During hospitalization, the investigators recorded MI complications, according to which the patients were divided into favorable and unfavorable MI groups. On day 1 of hospitalization, the level of ST2 in the patients with unfavorable MI was twice higher than in those with favorable MI and 3.7 times higher than in the control group. On day 12, both favorable and unfavorable MI groups showed a reduction in the level of the marker. On day 1 of MI, the concentration of NT-proBNP in the patients with a poor prognosis was 6.8 times greater than in the controls and 1.8 times more than in the patients with a good prognosis. On day 12, NT-proBNP levels remained elevated in both groups. Logistic regression analysis revealed that the determination of ST2 in combination with NT-proBNP increased their diagnostic significance (odds ratio, 1.92; 95% CI, 1.7—3.2; area under characteristic curve, 0.89; p=0.004). Conclusion. The level of ST2 was a more sensitive indicator of hospitalization for MI than that of NT-proBNP. The combined use of ST2 and NT-proBNP was found to have a high diagnostic sensitivity and specificity.
topic myocardial infarction
hospitalization
stimulating growth factor st2
n-terminal pro-brain natriuretic peptide (nt-probnp)
url https://ter-arkhiv.ru/0040-3660/article/viewFile/31952/pdf
work_keys_str_mv AT ovgruzdeva diagnosticvalueofthestimulatinggrowthfactorst2duringhospitalizationformyocardialinfarction
AT oeakbasheva diagnosticvalueofthestimulatinggrowthfactorst2duringhospitalizationformyocardialinfarction
AT eguchasova diagnosticvalueofthestimulatinggrowthfactorst2duringhospitalizationformyocardialinfarction
AT yuadyleva diagnosticvalueofthestimulatinggrowthfactorst2duringhospitalizationformyocardialinfarction
AT nvfedorova diagnosticvalueofthestimulatinggrowthfactorst2duringhospitalizationformyocardialinfarction
AT vnkaretnikova diagnosticvalueofthestimulatinggrowthfactorst2duringhospitalizationformyocardialinfarction
AT vvkashtalap diagnosticvalueofthestimulatinggrowthfactorst2duringhospitalizationformyocardialinfarction
AT olbarbarash diagnosticvalueofthestimulatinggrowthfactorst2duringhospitalizationformyocardialinfarction
_version_ 1724679890297421824